{
    "info": {
        "nct_id": "NCT05900986",
        "official_title": "An Open-label, Single-arm, Phase 1b/2 Study to Investigate the Safety, Efficacy and Pharmacokinetics of LS301-IT in Female Patients Undergoing Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for Ductal Carcinoma in Situ (DCIS) or Stage I-II Primary Invasive Breast Cancer",
        "inclusion_criteria": "* DCIS (whether or not undergoing planned SLNB) or patients with Stage I-II, primary invasive carcinoma of the breast undergoing SLNB for which the patient's primary surgical treatment is single breast partial mastectomy.\n* ECOG performance status of 0 to 2\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
        "exclusion_criteria": "* Contraindications for surgery.\n* Simultaneous bilateral lumpectomies and bilateral partial mastectomies.\n* History of drug-related anaphylactic reactions, including those attributed to indocyanine green (ICG) or other agents used in the study\n* Prior chemotherapy, endocrine therapy, or biologic therapy for current clinically or biopsy proven breast cancer for Period 1.\n* Open surgery in the ipsilateral breast within a period of 1 year before administration of LS301-IT.\n* History of radiation therapy to the chest.\n* The lymphatic imaging agent ICG cannot be used prior to the partial mastectomy and SLNB procedures on the day of surgery.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 80 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 80 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 80,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must be FEMALE",
            "criterions": [
                {
                    "exact_snippets": "Must be FEMALE",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* DCIS (whether or not undergoing planned SLNB) or patients with Stage I-II, primary invasive carcinoma of the breast undergoing SLNB for which the patient's primary surgical treatment is single breast partial mastectomy.",
            "criterions": [
                {
                    "exact_snippets": "DCIS (whether or not undergoing planned SLNB)",
                    "criterion": "ductal carcinoma in situ (DCIS)",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "patients with Stage I-II, primary invasive carcinoma of the breast",
                    "criterion": "primary invasive carcinoma of the breast",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": "Stage"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "Stage"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "undergoing SLNB",
                    "criterion": "sentinel lymph node biopsy (SLNB)",
                    "requirements": [
                        {
                            "requirement_type": "planned or performed",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "the patient's primary surgical treatment is single breast partial mastectomy",
                    "criterion": "primary surgical treatment",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": "single breast partial mastectomy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG performance status of 0 to 2",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status of 0 to 2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Open surgery in the ipsilateral breast within a period of 1 year before administration of LS301-IT.",
            "criterions": [
                {
                    "exact_snippets": "Open surgery in the ipsilateral breast within a period of 1 year before administration of LS301-IT.",
                    "criterion": "open surgery in the ipsilateral breast",
                    "requirements": [
                        {
                            "requirement_type": "time since procedure",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "year"
                            }
                        },
                        {
                            "requirement_type": "timing reference",
                            "expected_value": "before administration of LS301-IT"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of drug-related anaphylactic reactions, including those attributed to indocyanine green (ICG) or other agents used in the study",
            "criterions": [
                {
                    "exact_snippets": "History of drug-related anaphylactic reactions",
                    "criterion": "drug-related anaphylactic reactions",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including those attributed to indocyanine green (ICG)",
                    "criterion": "anaphylactic reactions attributed to indocyanine green (ICG)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "or other agents used in the study",
                    "criterion": "anaphylactic reactions attributed to other agents used in the study",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of radiation therapy to the chest.",
            "criterions": [
                {
                    "exact_snippets": "History of radiation therapy to the chest.",
                    "criterion": "radiation therapy to the chest",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Simultaneous bilateral lumpectomies and bilateral partial mastectomies.",
            "criterions": [
                {
                    "exact_snippets": "Simultaneous bilateral lumpectomies",
                    "criterion": "bilateral lumpectomies",
                    "requirements": [
                        {
                            "requirement_type": "simultaneity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Simultaneous ... bilateral partial mastectomies",
                    "criterion": "bilateral partial mastectomies",
                    "requirements": [
                        {
                            "requirement_type": "simultaneity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Contraindications for surgery.",
            "criterions": [
                {
                    "exact_snippets": "Contraindications for surgery",
                    "criterion": "contraindications for surgery",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* The lymphatic imaging agent ICG cannot be used prior to the partial mastectomy and SLNB procedures on the day of surgery.",
            "criterions": [
                {
                    "exact_snippets": "The lymphatic imaging agent ICG cannot be used prior to the partial mastectomy and SLNB procedures on the day of surgery.",
                    "criterion": "use of lymphatic imaging agent ICG prior to partial mastectomy and SLNB procedures on the day of surgery",
                    "requirements": [
                        {
                            "requirement_type": "prohibition",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "line": "* Prior chemotherapy, endocrine therapy, or biologic therapy for current clinically or biopsy proven breast cancer for Period 1.",
            "criterions": [
                {
                    "exact_snippets": "Prior chemotherapy ... for current clinically or biopsy proven breast cancer for Period 1.",
                    "criterion": "prior chemotherapy for current breast cancer (Period 1)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Prior endocrine therapy ... for current clinically or biopsy proven breast cancer for Period 1.",
                    "criterion": "prior endocrine therapy for current breast cancer (Period 1)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Prior ... biologic therapy for current clinically or biopsy proven breast cancer for Period 1.",
                    "criterion": "prior biologic therapy for current breast cancer (Period 1)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "failed_miscellaneous": []
}